The Cloning and Expression of Carboxyl Terminal Part of Protective Antigen from Bacillus Anthracis

BACKGROUND AND OBJECTIVE: Antibody production against to protective antigen (PA) can be helpful in immunotherapy and anthrax treatment. The carboxyl terminal part of PA has the most important playing in immune system induction. The objective of this study is cloning and recombinant expression of car...

Full description

Bibliographic Details
Main Author: Keyhan AH, Tahmasbpour Marzony E, Farhadi N, Kamali M
Format: Article
Language:English
Published: Babol University of Medical Sciences 2011-09-01
Series:Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
Subjects:
Online Access:http://jbums.org/article-1-3867-en.html
_version_ 1818931919692234752
author Keyhan AH, Tahmasbpour Marzony E, Farhadi N, Kamali M
author_facet Keyhan AH, Tahmasbpour Marzony E, Farhadi N, Kamali M
author_sort Keyhan AH, Tahmasbpour Marzony E, Farhadi N, Kamali M
collection DOAJ
description BACKGROUND AND OBJECTIVE: Antibody production against to protective antigen (PA) can be helpful in immunotherapy and anthrax treatment. The carboxyl terminal part of PA has the most important playing in immune system induction. The objective of this study is cloning and recombinant expression of carboxyl site of protective protein for antibody production.METHODS: In this experimental study after DNA extraction from Bacillus anthracis, the presence of PA gene on bacterial chromosome was confirmed by PCR method. The site of carboxyl terminal from PA protein amplified by PCR method, then PCR productions and plasmid were cut out by BamH I and Hind III restriction enzymes. PCR production and plasmid transformed into E. coli BL21 (DE3). Clones containing gene of interest was determined by PCR reaction, enzyme digestion and sequencing. Moreover, the production of recombinant proteins was confirmed by SDS-PAGE and western methods.FINDINGS: The sequence of carboxyl terminal part of PA was confirmed by sequencing, PCR and enzymatic digestion method which suggestion to intended gene cloning in E. coli BL21 (DE3). SDS-PAGE and western blotting confirmed the production of recombinant protein with 20 KD in molecular weight.CONCLUSION: According to the results of this study, this recombinant protein can be produced in high levels by this method, which opens a new window for vaccine and monoclonal antibody production against the intended disease.
first_indexed 2024-12-20T04:24:15Z
format Article
id doaj.art-8d3d00619f124d7a97c56e7de44193c2
institution Directory Open Access Journal
issn 1561-4107
2251-7170
language English
last_indexed 2024-12-20T04:24:15Z
publishDate 2011-09-01
publisher Babol University of Medical Sciences
record_format Article
series Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
spelling doaj.art-8d3d00619f124d7a97c56e7de44193c22022-12-21T19:53:33ZengBabol University of Medical SciencesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul1561-41072251-71702011-09-01135714The Cloning and Expression of Carboxyl Terminal Part of Protective Antigen from Bacillus AnthracisKeyhan AH, Tahmasbpour Marzony E, Farhadi N, Kamali M0 BACKGROUND AND OBJECTIVE: Antibody production against to protective antigen (PA) can be helpful in immunotherapy and anthrax treatment. The carboxyl terminal part of PA has the most important playing in immune system induction. The objective of this study is cloning and recombinant expression of carboxyl site of protective protein for antibody production.METHODS: In this experimental study after DNA extraction from Bacillus anthracis, the presence of PA gene on bacterial chromosome was confirmed by PCR method. The site of carboxyl terminal from PA protein amplified by PCR method, then PCR productions and plasmid were cut out by BamH I and Hind III restriction enzymes. PCR production and plasmid transformed into E. coli BL21 (DE3). Clones containing gene of interest was determined by PCR reaction, enzyme digestion and sequencing. Moreover, the production of recombinant proteins was confirmed by SDS-PAGE and western methods.FINDINGS: The sequence of carboxyl terminal part of PA was confirmed by sequencing, PCR and enzymatic digestion method which suggestion to intended gene cloning in E. coli BL21 (DE3). SDS-PAGE and western blotting confirmed the production of recombinant protein with 20 KD in molecular weight.CONCLUSION: According to the results of this study, this recombinant protein can be produced in high levels by this method, which opens a new window for vaccine and monoclonal antibody production against the intended disease.http://jbums.org/article-1-3867-en.htmlbacillus anthracispa proteincloninganthrax
spellingShingle Keyhan AH, Tahmasbpour Marzony E, Farhadi N, Kamali M
The Cloning and Expression of Carboxyl Terminal Part of Protective Antigen from Bacillus Anthracis
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
bacillus anthracis
pa protein
cloning
anthrax
title The Cloning and Expression of Carboxyl Terminal Part of Protective Antigen from Bacillus Anthracis
title_full The Cloning and Expression of Carboxyl Terminal Part of Protective Antigen from Bacillus Anthracis
title_fullStr The Cloning and Expression of Carboxyl Terminal Part of Protective Antigen from Bacillus Anthracis
title_full_unstemmed The Cloning and Expression of Carboxyl Terminal Part of Protective Antigen from Bacillus Anthracis
title_short The Cloning and Expression of Carboxyl Terminal Part of Protective Antigen from Bacillus Anthracis
title_sort cloning and expression of carboxyl terminal part of protective antigen from bacillus anthracis
topic bacillus anthracis
pa protein
cloning
anthrax
url http://jbums.org/article-1-3867-en.html
work_keys_str_mv AT keyhanahtahmasbpourmarzonyefarhadinkamalim thecloningandexpressionofcarboxylterminalpartofprotectiveantigenfrombacillusanthracis
AT keyhanahtahmasbpourmarzonyefarhadinkamalim cloningandexpressionofcarboxylterminalpartofprotectiveantigenfrombacillusanthracis